Cargando…
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
The iron regulatory hormone hepcidin limits iron fluxes to the bloodstream by promoting degradation of the iron exporter ferroportin in target cells. Hepcidin insufficiency causes hyperabsorption of dietary iron, hyperferremia and tissue iron overload, which are hallmarks of hereditary hemochromatos...
Autores principales: | Sebastiani, Giada, Wilkinson, Nicole, Pantopoulos, Kostas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914558/ https://www.ncbi.nlm.nih.gov/pubmed/27445804 http://dx.doi.org/10.3389/fphar.2016.00160 |
Ejemplares similares
-
Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
por: Nemeth, Elizabeta
Publicado: (2010) -
Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction
por: Ross, Sandra L., et al.
Publicado: (2017) -
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
por: Hawula, Zachary J., et al.
Publicado: (2019) -
A crosstalk between hepcidin and IRE/IRP pathways controls ferroportin expression and determines serum iron levels in mice
por: Charlebois, Edouard, et al.
Publicado: (2022) -
The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes
por: Zughaier, Susu M., et al.
Publicado: (2014)